{"schema_version":"secwatch.filing_event.v1","accession":"0001683168-26-005458","form_type":"8-K","ticker":"SBFM","cik":"0001402328","company_name":"Sunshine Biopharma Inc.","filed_at":"2026-07-10T20:54:05+00:00","discovered_at":"2026-07-10T20:55:00.274616+00:00","generated_at":"2026-07-10T20:55:04.631390+00:00","sec_items":["1.01","9.01"],"event_type":"litigation","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Sunshine Biopharma settles dispute with former Nora Pharma president for CAD$1.5M","bullets":["Company to pay CAD$1.5M (approx US$1.06M) to Malek Chamoun to settle all claims and cross-claims.","Settlement includes earn-out, bonuses, indemnity in lieu of notice, and expense reimbursement; no admission of liability.","Chamoun must sell all his Sunshine Biopharma shares within 30 days; non-compete and non-solicitation obligations terminated.","Mutual releases of all claims; parties agree to confidentiality and non-disparagement."],"urls":{"canonical":"https://secwatch.observer/filing/0001683168-26-005458","json":"https://secwatch.observer/filing/0001683168-26-005458.json","markdown":"https://secwatch.observer/filing/0001683168-26-005458.md","text":"https://secwatch.observer/filing/0001683168-26-005458.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1402328/000168316826005458/0001683168-26-005458-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1402328/000168316826005458/sunshine_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-07-10T20:55:04.631390+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}